Clinical Trial Update: Glivec in Ph Positive Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update of Glivec (imatinib) in Philadelphia chromosome-positive acute lymphoblastic leukemia; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Glivec (imatinib)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Lymphoblastic Leukemia, Cromosome Philadelphia Positive | Phase 2 | Status: COMPLETED